While xanthine oxidase inhibition is still the primary therapy for gout, it can also have serious adverse effects, such as skin rashes, hepatitis, fever, Stevens–Johnson syndrome, nephropathy, fatal liver necrosis, allergic reactions, and cardiovascular events. The gene discussed is XDH; the disease is gout.